Accredited Investors Inc. Dexcom Inc Transaction History
Accredited Investors Inc.
- $1.55 Billion
- Q2 2024
A detailed history of Accredited Investors Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Accredited Investors Inc. holds 4,507 shares of DXCM stock, worth $317,653. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,507
Previous 4,643
2.93%
Holding current value
$317,653
Previous $643,000
20.53%
% of portfolio
0.03%
Previous 0.04%
Shares
17 transactions
Others Institutions Holding DXCM
# of Institutions
1,066Shares Held
361MCall Options Held
4.11MPut Options Held
3.61M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.28 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.43 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.15 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.08 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$842 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $27.2B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...